MD Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Pediatrix Medical Group Inc (MD) is not a strong buy for a beginner, long-term investor at this time. The stock lacks positive momentum, has mixed financial performance, and no significant catalysts or trading signals to suggest an immediate entry point. Holding off on investment until clearer signs of growth or positive sentiment emerge is recommended.
The MACD is positive and expanding, indicating mild bullish momentum. RSI is neutral at 57.27, showing no overbought or oversold conditions. Moving averages are converging, suggesting indecision in price direction. The stock is trading near its pivot point of 19.624, with resistance at 20.171 and support at 19.078.
Net income increased by 10.51% YoY, and EPS rose by 11.11% YoY in Q4 2025, indicating some financial improvement.
Analysts have lowered price targets due to weaker-than-expected volumes and ACA headwinds. No recent news or significant insider/hedge fund activity. Stock trend analysis suggests a potential decline in the short term.
In Q4 2025, revenue dropped to $493.77M (-1.71% YoY), while net income increased to $33.68M (+10.51% YoY). EPS improved to $0.40 (+11.11% YoY), and gross margin remained flat at 100%.
Analysts have lowered price targets recently: UBS to $22 (Neutral), Deutsche Bank to $19 (Hold), and Truist to $21 (Hold). Concerns include weaker Q4 volumes and ACA headwinds.
